Seed VC · Singapore, Singapore
4BIO Capital is a London-based investment firm founded in 2018, specializing in advanced therapies and biotechnology. The company focuses on funding and supporting early-stage and growth-stage companies developing innovative treatments in areas such as gene therapy, cell therapy, RNA-based drugs, and targeted therapies. 4BIO Capital manages several funds and collaborates with academic institutions, research organizations, and industry partners to accelerate the development of transformative medical solutions. The firm is recognized for its expertise in the life sciences sector and its commitment to advancing next-generation therapeutics.
Business models
biotech_therapeutics, deeptech_ip
Customer segments
Researchers, Healthcare providers
Geography
UK, Europe, USA, APAC
We never publish partner emails directly — score your deck to unlock contacts for the firms ranked as best-fit.
4BIO Capital writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. VCboom tracks 4BIO Capital alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.
Seed VC
TVM Capital Healthcare
healthcare, life sciences, medical devices
Seed VC
Gold Nest Capital
life sciences, healthcare, biotech
Seed VC
Gold Nest Capital
life sciences, healthcare, biotech
Family Office
Aeternum Management AS
life sciences, healthcare, medical devices
Seed VC
Vespa Capital
tech-enabled services, software, life sciences
Family Office
SK Capital Partners
specialty materials, ingredients, life sciences
Drop your pitch. AI scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. 4BIO Capital is one of them — and we'll tell you exactly where they sit in your top 100.